LYRICA

In the US, LYRICA (pregabalin systemic) is a member of the drug class gamma-aminobutyric acid analogs and is used to treat Diabetic Nerve Damage, Epilepsy, Fibromyalgia, Generalized Anxiety Disorder, Migraine Prevention, Neuralgia, Pain, Peripheral Neuropathy, Persisting Pain - Shingles, Reflex Sympathetic Dystrophy Syndrome and Restless Legs Syndrome.

US matches:

• Lyrica

UK matches:

• Lyrica Capsules (SPC)

Ingredient matches for LYRICA

Pregabalin

Pregabalin is reported as an ingredient of LYRICA in the following countries:

• Argentina


• Australia


• Austria


• Belgium


• Belize


• Bulgaria


• Canada


• Chile


• Colombia


• Costa Rica


• Croatia (Hrvatska)


• Cyprus


• Czech Republic


• Denmark


• Ecuador


• El Salvador


• Finland


• France


• Germany


• Greece


• Guatemala


• Honduras


• Hong Kong


• Hungary


• Iceland


• Indonesia


• Ireland


• Israel


• Italy


• Luxembourg


• Mexico


• Netherlands


• New Zealand


• Nicaragua


• Norway


• Oman


• Panama


• Peru


• Philippines


• Poland


• Portugal


• Romania


• Russian Federation


• Serbia


• Singapore


• Slovakia


• Slovenia


• South Africa


• Spain


• Sweden


• Switzerland


• Thailand


• Tunisia


• Turkey


• United Kingdom


• United States


• Venezuela


• Vietnam

International Drug Name Search

Glossary

SPC	Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.